MS
NUVB icon

Maven Securities’s Nuvation Bio NUVB Stock Holding History

Maven Securities’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-40,000
Closed -$370K – 1205
2021
Q2 		$370K Buy
40,000
+35,491
+787% +$405K 0.01% 775
2021
Q1 		$47K Buy
+4,509
New +$50.4K ﹤0.01% 1095

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Maven Securities's NUVB Position: Q3 2021 in Review

Maven Securities sold out of Nuvation Bio (NUVB) in Q3 2021, closing a stake of 40,000 shares — an estimated $370K sold.

Maven Securities first reported a position in NUVB in Q1 2021 and held it in 2 quarters. The position peaked at $370K in Q2 2021. 98 funds tracked by Wall St. Rank hold NUVB as of Q3 2021.

  • Maven Securities reported no remaining Nuvation Bio position as of Q3 2021 after selling out during the quarter.
  • Maven Securities sold 40,000 Nuvation Bio shares in Q3 2021, an estimated $370K.
  • Maven Securities first reported a position in Nuvation Bio in Q1 2021 and held it in 2 quarters.
  • Maven Securities's Nuvation Bio position peaked at $370K in Q2 2021.
  • 98 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2021.

Based on Maven Securities's 13F filing for Q3 2021, filed 15 Nov 2021.